Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Lundbergs Interim report January - March 2021

· On March 31, 2021, net asset value after deferred tax amounted to SEK 118.6 billion (SEK 478 per share), compared with SEK 110.7 billion (SEK 446 per share) on December 31, 2020. The corresponding values on May 21, 2021 were SEK 123.0 billion (SEK 496 per share).  · Consolidated net sales amounted to SEK 6,234 m. (5,414).  · Profit after financial items amounted to SEK 5,229 m. (-2,750) where earnings from participations in associated companies amounted to SEK 3,497 m. (-2,982). Profit after financial items excluding unrealized changes in value amounted to SEK 5,109 m. (-2,096).

Artificial Solutions further expands its Conversational AI platform reach to 86 languages

Artificial Solutions today announced support for two additional languages, Korean and Albanian, to the already supported 84 languages, further expanding the company's global footprint.With the company’s built-in language support covering close to 40% of the world’s population, the Conversational AI platform can deliver assistance in multiple languages to audiences worldwide. Artificial Solutions provides the most extensive conversational AI language solution in the market. “Our technology can deliver solutions in languages that haven’t been catered to before, and our approach is to

BioStock: BiBBInstruments resumes key clinical trials

Cancer diagnostics company BiBBInstruments released its 2020 annual report last week where the company outlines its main achievements from last year, including the launch of clinical evaluation of the world’s first CE-marked electric endoscopic biopsy instrument. Due to production problems, in April 2021, BiBBInstruments had to pause the recruitment of patients in its two ongoing clinical studies. However, in mid-May, after intensive work, the company was able to announce that studies could be resumed after a complete change of supplier.Read the article at biostock.se: https://www.

REPORT FROM THE ANNUAL GENERAL MEETING OF SCOUT GAMING GROUP

At the annual general meeting (the “AGM”) of Scout Gaming Group AB (publ), reg. no 559119-1316, (the “Company”), on 25 May 2021 the AGM adopted, inter alia, the following resolutions. For more detailed information regarding the contents of the resolutions, please refer to the notice to the AGM and the complete proposals, which have previously been published and are available on the Company’s website, www.scoutgaminggroup.com.Adoption of the balance sheet and income statement, disposition regarding the Company’s results and discharge from liability The AGM resolved to allocate the

Innovation in focus at BioStock Life Science Spring Summit 2021

As last year, this year’s flagship event, the Life Science Spring Summit, is held as a virtual two-day event. Tomorrow and Thursday, as many as twenty six companies will present their projects in a large number of therapeutic areas, either from BioStock’s studio in Lund, or via link. The event, which will be held in collaboration with Nasdaq and Potter Clarkson, also offers panel discussions with a trio of financial experts, as well as a deep dive into company valuations in biotechnology.Read the full article at biostock.se: https://www.biostock.se/en/innovation-in-focus-at-biostock-life-

Green Landscaping completes the acquisition of EF Drift AS

Green Landscaping Group AB (publ) har idag slutfört det tidigare kommunicerade förvärvet av EF Drift AS i Oslo.On 21 May, Green Landscaping Group communicated that Green Landscaping Group had entered into an agreement to acquire EF Drift AS. The transaction was completed today and Green Landscaping Group pays the purchase price in cash and by issuance of new shares to the seller. In connection with completion of the transaction, Green Landscaping Group’s board of directors has resolved to carry out a new share issue by contribution in kind, using the authorization previously granted by

William Hill opens for business in Colombia

Following the acquisition of a majority stake in the Colombia licensed operator Alfabet S.A.S in December 2020, WilliamHill.co was today launched, making Colombia its first entry in the Latin American market.Alfabet S.A.S. holds internet-operated games license C-1611, authorized by Coljuegos (Colombian gambling regulator) to offer sports betting and online casino games. By rebranding the consumer-facing sports book brand BetAlfa.co, William Hill managed to enter the Colombian market within a few months after the acquisition. The launch of WilliamHill.co supports William Hill’s strategy to

Salmon Evolution ASA: New company name registered

Reference is made to the stock exchange announcement by Salmon Evolution Holding ASA (the “Company”) published on 19 May 2021, regarding the 2021 minutes from the annual general meeting in the Company held on the same day whereby it was, inter alia, resolved to change the Company’s name to Salmon Evolution ASA. The name change has now been registered with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret), following which the Company’s legal name is Salmon Evolution ASA. The Company’s ticker on Euronext Growth (“SALME”) and ISIN remain unchanged.

As Farm to Fork Strategy impacts the indulgence sector, Valio’s dairy-based solution helps reduce sugar without artificial sweeteners

Tightening regulations around sugar and the increasing consumer demand for better-for-you choices have a major impact on the indulgence category. As a result, confectionery manufacturers are looking for ways to reduce sugar while maintaining the naturality of their products. With Valio’s solution, sugar reduction is achieved with dairy ingredients without any artificial sweeteners.EU regulations concerning unhealthy foods are expected to increase and tighten in the coming years. The EU’s European Green Deal plan includes a Farm to Fork Strategy that impacts the production of food. Its aim

Payments to governments

ENQUEST PLC, 25 MAY 2021 Reports on Payments to Governments for the Year ended 31 December 2020 This report provides information in accordance with DTR 4.3A in respect of payments made by the Company to Governments for the year ended 31 December 2020 and in compliance with the Reports on Payments to Governments Regulations 2014 (SI 2014/3209). This report is available to download from: https://www.enquest.com/environmental-social-and-governance/governance/business-conduct Basis of preparationThe payments disclosed, which are on a cash basis, are based on where the obligation for

MPC Energy Solutions looks to bolster renewable energy in the Caribbean as part of a post-COVID recovery process

Amsterdam/Oslo – 25 May 2021 – The sponsor of MPCES, MPC Capital, joined the CGI Action Network in 2020 and announced a commitment to raise USD 90m from US-based impact investors, institutional investors and foundations over a two-year period to fund renewable energy infrastructure projects. Giving an update on progress regarding efforts to mobilize and deploy finance in the region, Martin Vogt, CEO of MPC Energy Solutions, will address the CGI Action Network’s meeting on Post-Disaster Recovery on the 25th of May. Governments across the world, including in the Caribbean, have pledged to

Eco Wave Power Publishes First Financial Quarter Update While Announcing that an Interim Report for Q1 2021 Will Not be Published in Accordance with the Financial Calendar Previously Announced

25/05/2021- Stockholm, Sweden – EWPG Holding AB (publ) (Eco Wave Power) announces today that the Company will not publish an Interim Report for January–March 2021, in part due to an ongoing regulatory process with the U.S. Securities and Exchange Commission , related to the potential registration of Eco Wave Power’s shares in the U.S.Publication of Interim Reports for the first and third financial quarters is not mandatory under the First North rulebook and has historically been upheld by Eco Wave Power on a voluntary basis. The Company will be continuously evaluating the relevant frequency

Invitation to SAS’ Q2 2021 teleconference

SAS will publish the interim report for the second quarter of the fiscal year 2021 on Thursday, 27 of May 2021, at approximately 08.00 AM (CET). A teleconference and webcast for investors, analysts and media will be held at 10.00 AM (CEST). Karl Sandlund, acting President & CEO and Magnus Örnberg, Executive Vice President & CFO will present and comment the report. The presentation will be held in English via telephone or https://www.sasgroup.net No advance notification is necessary. Dial-in details for the conference call: DK: +45 354 455 77 FI: +358 981 710 310 NO: +47 235

Kojamo Plc: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act

Kojamo Plc Stock Exchange Release, 25 May 2021 at 12:00 noon EESTFlagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act Kojamo plc (the "Company") has on 25 May 2021 received a notification pursuant to Chapter 9, Section 5 of the Securities Markets Act from Teollisuusliitto Ry. According to the notification, the holding of Teollisuusliitto Ry in the Company's shares and votes has fallen below 10 per cent on 24 May 2021. This company holds a total of 24,409,561 shares corresponding to an ownership of 9.87664 percent. Total position of

Valokuitunen secures strong lender financing for roll-out of fibre networks in Finland

CapMan Infra press release 25 May 2021 at 12.00 noon EEST Valokuitunen secures strong lender financing for roll-out of fibre networks in Finland Valokuitunen Oy, a joint venture between CapMan Infra and Telia, has secured 5-year loan facilities with Skandinaviska Enskilda Banken (SEB) and Nordic Investment Bank (NIB) for financing the roll-out of new fibre-to-the-home network connections in Finland. The financing will continue to support Valokuitunen’s investments into new digital infrastructure and services, and expand the coverage of high-speed fixed line connections in

Inhalation Sciences signs exclusive distribution agreement with Sanyo Trading, Japan

(Stockholm, Sweden, May 25, 2021) The agreement grants Sanyo Trading exclusive sales rights to ISAB instruments in Japan, with a minimum purchasing commitment of 3 000 000 SEK in 2021 and a minimum of 5 000 000 SEK in 2022.ISAB has significantly strengthened its global sales strategy recently, with increased activities in the US and the signing of a new distribution agreement covering India, Bangladesh and Sri Lanka. Japan is a key target market for ISAB, with a large population, a robust research sector, advanced technology and strong pricing levels. Founded in 1947, Sanyo Trading is

BioStock: Iconovo's high aiming business goals

Last week, Iconovo announced its financial targets for 2026. In five years, the company expects to have ten projects in development and five launched inhalation products that generate royalties. In addition, the goal is to enter into 1 – 3 new customer agreements per year on the way there. All in all, this is expected to generate sales of 200 million SEK and an operating profit of 100 million SEK in 2026. Iconovo also sees two potential upsides: royalty revenue from innovative inhalation products as well as from royalty revenue from generic Symbicort in the US.Read the full article at

Medivir to present at the ABGSC Life Science Summit

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announces that the company will present at the virtual meeting ABGSC Life Science Summit, today, May 25. The company will be represented by Magnus Christensen, interim CEO, and Fredrik Öberg, Chief Scientific Officer. The presentation will be available after the seminar on Medivirs website; www.medivir.com. For additional information, please contactMagnus Christensen, interim CEO and CFOTelephone: +46 8 5468 3100E-mail: magnus.christensen@medivir.com  Medivir in briefMedivir develops innovative drugs with a focus on

KEBNI RELEASES QUARTERLY REPORT FOR Q1 2021, JANUARY-MARCH

Stockholm, 25 May 2021 Events January-March 2021 · On February 1, Torbjörn Saxmo took over as the new CEO of KebNi. · At the beginning of March, KebNi carried out a directed new share issue that brought in approximately SEK 12,141,000, and KebNi thus gained a long-term major shareholder. · At the end of March, KebNi carried out a directed new share issue that brought in approximately SEK 26,220,000, thereby securing several more long-term major shareholders and strengthening capital for the year. Key figures · Net sales amounted to 1,788 (14,100) KSEK · Operating profit

SimCorp A/S – Share buyback program

Company Announcement no. 22/2021On February 10, 2021 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 20.0m, to be executed during the period from February 10, 2021 to July 31, 2021. The following transactions have been executed under the program:          Date                 Number of shares

Isofol publishes prospectus in connection with the fully guaranteed preferential rights issue of approximately SEK 400 million

GOTHENBURG, Sweden, May 25, 2021 - Isofol Medical AB’s (publ), (Nasdaq First North Premier Growth Market: ISOFOL), (“Isofol or the “Company”) Board of Directors resolved on May 18, 2021, on an issue of shares of a maximum of 62,524,474 shares with preferential rights for the Company’s existing shareholders (the “Rights Issue”). If the Rights Issue is fully subscribed, the Company will receive approximately SEK 400 million before transaction costs related to the Rights Issue. In connection with the Rights Issue, the Company publishes a prospectus which today has been approved and registered by

There are no items matching the current filter
There are no more items matching the current filter
Back to top